BioFactura’s Ustekinumab Biosimilar To Be Trialed As ‘Robotic’ Pill

US-Based Firm Signs Agreement With CA-Based Rani Therapeutics

 
• By Dean Rudge
  
partnership
Rani recently completed an IPO, raising $73m • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products